Início › Câncer de Mama › Califórnia › Baldwin Park
Ensaios clínicos de Câncer de Mama em Baldwin Park, CA
44 estudos para Câncer de Mama estão buscando participantes em locais em Baldwin Park e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
RecrutandoFase 3
- City of Hope National Medical Center, Duarte · a 4 mi de distância
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
RecrutandoFase 2
- City of Hope - Duarte Cancer Center, Duarte · a 4 mi de distância
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
RecrutandoFase 3
- City of Hope National Medical, Duarte · a 4 mi de distância
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RecrutandoFase 2
- City of Hope, Duarte · a 4 mi de distância
Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.
RecrutandoFase 2
- City of Hope Medical Center, Duarte · a 4 mi de distância
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
RecrutandoFase 1
- City of Hope Comprehensive Cancer Center, Duarte · a 4 mi de distância
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
RecrutandoFase 1
- Research Site, Duarte · a 4 mi de distância
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
RecrutandoFase 2
- City of Hope, Duarte · a 4 mi de distância
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
RecrutandoFase 1
- City of Hope, Duarte · a 4 mi de distância
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RecrutandoFase 3
- City of Hope, Duarte · a 4 mi de distância
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
RecrutandoFase 2
- City of Hope, Duarte · a 4 mi de distância
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
RecrutandoFase 3
- City of Hope Comprehensive Cancer Center, Duarte · a 4 mi de distância
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
RecrutandoFase 1/2
- City of Hope, Duarte · a 4 mi de distância
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
RecrutandoFase 3
- City of Hope National Medical Center, Duarte · a 4 mi de distância
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
RecrutandoFase 1/2
- City of Hope - Duarte, Duarte · a 4 mi de distância
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
RecrutandoFase 1
- City of Hope, Duarte · a 4 mi de distância
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
RecrutandoFase 3
- Research Site, Duarte · a 4 mi de distância
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
RecrutandoFase 1/2
- City of Hope, Duarte · a 4 mi de distância
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
RecrutandoFase 1/2
- City of Hope, Duarte · a 4 mi de distância
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RecrutandoFase 3
- Kaiser Permanente-Baldwin Park, Baldwin Park
Environmental Exposure Assessment in High-Risk and Early-Onset Breast Cancer Care
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- City of Hope Medical Center, Duarte · a 4 mi de distância
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
RecrutandoFase 1
- City of Hope, Duarte · a 4 mi de distância
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
RecrutandoFase 2
- City of Hope--Duarte, Duarte · a 4 mi de distância
A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer
Recrutando
- City of Hope Medical Center, Duarte · a 4 mi de distância
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
RecrutandoFase 3
- City of Hope - Duarte Cancer Center, Duarte · a 4 mi de distância
E-Mindfulness Approaches for Living After Breast Cancer
RecrutandoFase 3
- Kaiser Permanente-Baldwin Park, Baldwin Park
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
RecrutandoFase 1
- City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte · a 4 mi de distância
Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
RecrutandoFase 2
- City of Hope Comprehensive Cancer Center, Duarte · a 4 mi de distância
An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis
RecrutandoFase 4
- City of Hope Medical Center, Duarte · a 4 mi de distância
Investigating the Feasibility and Acceptability of an Innovative Interdisciplinary Supportive Care Program: Couples Coping Together Against Cancer
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- City of Hope Medical Center, Duarte · a 4 mi de distância
Cemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Breast Cancer
RecrutandoFase 2
- City of Hope Medical Center, Duarte · a 4 mi de distância
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
RecrutandoFase 3
- City of Hope Medical Center, Duarte · a 4 mi de distância
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
RecrutandoFase 2
- City of Hope, Duarte · a 4 mi de distância
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Recrutando
- Beckman Research Institute of City of Hope, Duarte · a 4 mi de distância
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
RecrutandoFase 1
- City of Hope, Duarte · a 4 mi de distância
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- City of Hope, Duarte · a 4 mi de distância
Effects of White Button Mushroom on Inflammation in Obese Postmenopausal Women at High Risk of Breast Cancer
RecrutandoVoluntários saudáveis bem-vindos
- City of Hope Medical Center, Duarte · a 4 mi de distância
Photon Craniospinal Irradiation for the Treatment of Leptomeningeal Disease Secondary to Breast Cancer or Non-small Cell Lung Cancer
RecrutandoFase 2
- City of Hope Medical Center, Duarte · a 4 mi de distância
Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors
RecrutandoFase 2
- City of Hope Medical Center, Duarte · a 4 mi de distância
Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer
RecrutandoFase 2
- City of Hope Medical Center, Duarte · a 4 mi de distância
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecrutandoEstudo observacional
- Massive Bio SYNERGY-AI site, Duarte · a 4 mi de distância
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
RecrutandoFase 3
- City of Hope Comprehensive Cancer Center, Duarte · a 4 mi de distância
Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer
RecrutandoFase 2
- City of Hope Medical Center, Duarte · a 4 mi de distância
Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)
RecrutandoFase 1
- City of Hope Medical Center, Duarte · a 4 mi de distância
Ensaios de Câncer de Mama em outras cidades
- New York City, NY136 estudos
- Houston, TX126 estudos
- Boston, MA112 estudos
- Nashville, TN81 estudos
- Los Angeles, CA73 estudos
- Edison, NJ68 estudos
- St. Louis, MO64 estudos
- Queens, NY64 estudos
- Durham, NC64 estudos
- Chicago, IL59 estudos
- Philadelphia, PA56 estudos
- Dallas, TX55 estudos
Outros estudos em Baldwin Park
- Leucemia Mieloide Aguda40 estudos
- Câncer Colorretal37 estudos
- Câncer de Pulmão de Não Pequenas Células36 estudos
- Câncer (todos os tipos)34 estudos
- Câncer de Próstata30 estudos
- Câncer Metastático30 estudos
- Síndromes Mielodisplásicas26 estudos
- Câncer de Ovário25 estudos
- Câncer de Pulmão24 estudos
- Mieloma Múltiplo23 estudos
- Câncer de Estômago22 estudos
- Leucemia Linfoblástica Aguda21 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.